Abstract: An apparatus and method for determining the presence of a disease by analyzing a specimen by providing a vial partially containing the specimen and partially containing a headspace above the specimen, injecting an inert gas into the specimen in the vial to cause bubbling of the gas throughout at least a portion of the specimen such that the gas mixes with volatile organic compounds (VOCs) present in the specimen to create a VOC/gas mixture that is released into the headspace, collecting the VOC/gas mixture from the headspace in the vial, supplying the VOC/gas mixture to a chamber within the apparatus, causing the VOC/gas mixture to pass over a sensor array in proximity to the chamber, the sensor array generating an electrical signal as a function of VOCs detected in the VOC/gas mixture, and processing the electrical signal to determine the presence of a disease in the specimen.

Abstract: Disclosed embodiments relate to a method implemented by computing systems for generating a set of media-file-specific fingerprints for filtering out targeted content in a media file. Systems access a media file and generate a data representation of the media file that represents intrinsic attributes of the media file. Next, systems identify one or more data structures of targeted content in the data representation. After identifying the different data structures comprising targeted content, systems generate a set of fingerprints of the one or more data structures. Systems are configured to receive a request to stream the media file and generate a plurality of segments of the media file to be transmitted to a media player for sequential playback. Systems then compare each segment of the plurality of segments against the set of fingerprints and refrain from transmitting the particular segment to the media player.

Abstract: An apparatus and method for determining the presence of a disease by analyzing a specimen by providing a vial partially containing the specimen and partially containing a headspace above the specimen, injecting an inert gas into the specimen in the vial to cause bubbling of the gas throughout at least a portion of the specimen such that the gas mixes with volatile organic compounds (VOCs) present in the specimen to create a VOC/gas mixture that is released into the headspace, collecting the VOC/gas mixture from the headspace in the vial, supplying the VOC/gas mixture to a chamber within the apparatus, causing the VOC/gas mixture to pass over a sensor array in proximity to the chamber, the sensor array generating an electrical signal as a function of VOCs detected in the VOC/gas mixture, and processing the electrical signal to determine the presence of a disease in the specimen.

Abstract: a first electronic device includes: a first transceiver; at least one first processor; and a first memory configured to store at least one instruction which, when executed by the at least one first processor, causes the first electronic device to: transmit an action frame to a second electronic device, wherein the action frame includes a request that any DL TXOP initiated by the second electronic device begin with an ICF that signals a duration of the DL TXOP, receive the ICF requesting the DL TXOP from the second electronic device, wherein the ICF signals the duration of the DL TXOP, based on determining that a Coex event is scheduled to occur during the duration of the DL TXOP, transmit a CTS-EXT frame signaling a modification to the DL TXOP, and, after the modification is implemented, receive at least one frame during the DL TXOP according to the modification.

Abstract: Fast response color waveforms for driving multi-particle color electrophoretic media to improve the user experience of a display, e.g. a tablet, monitor, or interactive sign, that incorporates multi-particle color electrophoretic media. In particular, the waveforms result in a sharp and immediate response, which is preferred when writing with a stylus, or typing on a keyboard, or interacting with an icon on a sign, such as a timetable.

Abstract: A method for creating waveforms having a multi-transition structure for driving color electrophoretic displays is described. The method includes generating a set of seed candidate waveforms, and applying each seed candidate waveform to the display pixels of the color electrophoretic display. The method includes measuring the optical state of each color created at the display pixels by applying the seed candidate waveforms, and selecting a set of seed waveforms based on the optical measurements of the colors produced by applying each seed candidate waveform. The method also includes generating a first sequence of perturbation waveforms, and applying each perturbation waveform of the first sequence of perturbation waveforms to each seed waveform of the color electrophoretic display. The method also includes measuring the optical state of each color created at the display pixels by applying each perturbation waveform of the first sequence to each seed waveform.

Abstract: A rotary dispenser (100) for unwinding a telecommunications cable (115) from a drum (110), the rotary dispenser comprising: a rotating portion (125) for supporting the drum and for permitting rotation of the drum about an axis of rotation; a fixed portion (120) supporting the rotating portion and configured to remain static relative to the rotating portion; a locating member (135) for centring the drum about the axis of rotation; a cable guide (145), coupled to the fixed portion, for receiving the telecommunications cable from the drum when the drum is mounted on the rotary dispenser and configured to support movement of the telecommunications cable through the cable guide as the rotating portion and the drum are rotated with the rotating portion; and an urging member for urging the cable guide away from the rotating portion so as to tension the telecommunications cable in use.

Abstract: A device for administering needle-free subcutaneous treatment to a patient comprises an actuator configured to deliver a plurality of volumes of a treatment at a plurality of locations on a body of the patient; at least one imaging device configured to detect a movement of the needle-free device from a first location on the body of the patient to a second location on the body of the patient; and a processor configured to determine the second location on the body of the device relative to the first location from the movement of the needle-free device relative to the first location on the body, the processor further configured to determine a volume of the plurality of volumes of the treatment to deliver to the body of the patient at the second location.

Abstract: A needle-free injector system includes a needle-free injector configured to deploy a dose of a treatment to a patient as an injection event, a gyroscope configured to monitor an orientation of the needle-free injector during the injection event, and a processor configured to perform steps of detecting that an actuator of the needle-free injector has deployed the dose in the injection event, monitoring a signal from the gyroscope during the injection event, determining an orientation of the needle-free injector during the injection event based on the signal from the gyroscope, determining whether the injection event was a treatment event including a successful delivery of the dose to the patient based on the orientation of the needle-free injector during the injection event, and transmitting information regarding the injection event to a server.

Abstract: An enclosure for a pair of interconnected telecommunications cables, each of the cables including a connector and a boot, and the enclosure including a housing for the pair of interconnected telecommunications cables; and an engagement formation configured to receive each connector and each boot of the pair of interconnected telecommunications cables and to fasten the telecommunications cables to the housing.

Abstract: A graph neural network (GNN) model is used in a scheduling process for compiling a deep neural network (DNN). The DNN, and parameter options for scheduling the DNN, are represented as a graph, and the GNN predicts a set of parameters that is expected to have a low cost. Using the GNN-based model, a compiler can produce a schedule for compiling the DNN in a relatively short and predictable amount of time, even for DNNs with many layers and/or many parameter options. For example, the GNN-based model reduces the overhead of exploring every parameter combination and does not exclude combinations from consideration like prior heuristic-based approaches.

Abstract: A method of driving a multi-pixel electrophoretic display that is designed to enable at least three colors, e.g., eight, at each pixel. This method uses a first drive scheme capable of effecting transitions between all of the color states that can be displayed at each pixel; and a second drive scheme that contains only transitions ending at white or black, which is very useful for drawing black lines on a white page, reading black text on a white page, or reading white text on a black page. In order to control the amount of impulse potential accumulated at each pixel during the switch between drive modes, two intermediate transitional modes are added.

Abstract: A needle-free injector system includes a needle-free injector configured to deploy a dose of a treatment to a patient as an injection event, a gyroscope configured to monitor an orientation of the needle-free injector during the injection event, and a processor configured to perform steps of detecting that an actuator of the needle-free injector has deployed the dose in the injection event, monitoring a signal from the gyroscope during the injection event, determining an orientation of the needle-free injector during the injection event based on the signal from the gyroscope, determining whether the injection event was a treatment event including a successful delivery of the dose to the patient based on the orientation of the needle-free injector during the injection event, and transmitting information regarding the injection event to a server.

Abstract: A device for administering needle-free subcutaneous treatment to a patient comprises an actuator configured to deliver a plurality of volumes of a treatment at a plurality of locations on a body of the patient; at least one imaging device configured to detect a movement of the needle-free device from a first location on the body of the patient to a second location on the body of the patient; and a processor configured to determine the second location on the body of the device relative to the first location from the movement of the needle-free device relative to the first location on the body, the processor further configured to determine a volume of the plurality of volumes of the treatment to deliver to the body of the patient at the second location.

Abstract: A device that performs wireless actuation by inductive heating. The device includes a bladder configured to expand or retract, so as to change the bladder's interior area. The device also includes a container, fluidly coupled to the bladder via a connector, that houses a magnetic rod suspended in a fluid medium. The magnetic rod is configured to react to a magnetic field that produces a phase transition of the fluid medium, causing the fluid medium to be transferred to the bladder's interior area, via the connector, expanding the bladder. The device further includes an induction coil, disposed around the container, and the induction coil's first end is coupled to the container's interior. The device also includes an induction heater, coupled to the induction coil's second end, that powers the induction coil, such that the induction coil generates the magnetic field within the container.

Abstract: Systems, devices, and methods are described herein that relate to massage devices with force control and feedback for providing pain relief and improved muscle recover to users. The massage devices can output mechanisms for applying a mechanical output to a muscle area of a user to treat a muscle condition, driving mechanisms for driving the movement of the output mechanisms, and sensors for measuring force and other properties associated with application of the mechanical output. The massage devices can be configured to adapt therapy being applied to a muscle area or provide users with feedback based on sensor measurements.

Abstract: A device for administering needle-free subcutaneous treatment to a patient comprises an actuator configured to deliver a plurality of volumes of a treatment at a plurality of locations on a body of the patient; at least one imaging device configured to detect a movement of the needle-free device from a first location on the body of the patient to a second location on the body of the patient; and a processor configured to determine the second location on the body of the device relative to the first location from the movement of the needle-free device relative to the first location on the body, the processor further configured to determine a volume of the plurality of volumes of the treatment to deliver to the body of the patient at the second location.

Abstract: A device for administering needle-free subcutaneous treatment to a patient comprises an actuator configured to deliver a plurality of volumes of a treatment at a plurality of locations on a body of the patient; at least one imaging device configured to detect a movement of the needle-free device from a first location on the body of the patient to a second location on the body of the patient; and a processor configured to determine the second location on the body of the device relative to the first location from the movement of the needle-free device relative to the first location on the body, the processor further configured to determine a volume of the plurality of volumes of the treatment to deliver to the body of the patient at the second location.

Abstract: Devices and methods for measuring phosphate levels in a fluid, such as natural water, are disclosed. The devices and methods rely upon the anodic dissolution of molybdenum to generate a reagent from a phosphate-containing fluid, which is then measured electrochemically to determine a level of phosphate ions in the fluid. The different embodiments of devices used for performing this technique are transportable and have extended lifetimes when compared to existing devices used to measure phosphate levels in fluid. They can be used in situ at the source of a site to generate results within about two minutes, within about thirty seconds, and even within about ten seconds. They also consume much less energy and molybdenum per measurement. The disclosed embodiments include devices having one or two molybdenum electrodes, with one of the electrodes disposed near a working electrode. Various methods for determining phosphate levels in fluids are also provided.

Abstract: A method of administering subcutaneous treatment to a patient is provided. The method includes delivering, by a needle-free injection device, a first volume of a treatment at a first location on a surface of a body of the patient; detecting a movement of the needle-free injection device relative to the first location; determining, from the movement of the needle-free injection device relative to the first location, a second location of the needle-free injection device relative to the first location; determining a second volume of the treatment to deliver at the surface of the body of the patient at the second location; and delivering, by the needle-free injection device, the second volume of the treatment at the second location on the surface of the body of the patient.